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Introduction
Defects in neural development are known to result in complex 
neurodevelopmental  disorders  including  mental  retardation, 
epilepsy, attention deficient hyperactivity disorder, autism, and 
schizophrenia (Ehninger et al., 2008; Walsh et al., 2008). In ad-
dition to genetic factors, environmental factors also contribute 
to these neurodevelopmental disorders. For instance, prenatal 
infection and maternal immune responses have been suggested 
to modulate neural development of embryos and can lead to 
autistic or schizophrenic behaviors (Hornig and Lipkin, 2001; 
Smith et al., 2007; Patterson, 2009). Therefore, it has been hy-
pothesized  that  innate  immune  responses  influence  neuronal 
development. Indeed, recent studies indicate that the Toll-like 
receptors (TLRs), key receptors for activation of innate immunity, 
regulate neurogenesis and neuritogenesis. TLR2 and TLR4 ac-
tivation regulate hippocampal neurogenesis (Rolls et al., 2007), 
whereas TLR3 plays a negative role in the proliferation of 
embryonic neural progenitor cells (Lathia et al., 2008). Both 
TLR3 and TLR8 negatively modulate neurite outgrowth (Ma 
et al., 2006; Cameron et al., 2007). Collectively, these studies 
strengthen the notion that innate immunity plays a regulatory 
role in neural development.
Sterile  and TIR motif–containing protein 1 (Sarm1) is a 
multidomain adaptor molecule containing two sterile  motifs 
and one Toll/interleukin-1 receptor homology domain. Sarm1 
was originally identified as a negative regulator of the TRIF- 
dependent TLR3 and TLR4 pathways in innate immunity (Mink 
et al., 2001; Carty et al., 2006). In addition, Sarm1 is known to   
function in the nervous system. Toll and interleukin 1 receptor 
domain protein (Tir-1), an orthologue of Sarm1 in Caenorhab-
ditis elegans, is highly concentrated at synapses (Chuang and 
Bargmann, 2005). Tir-1 receives synaptic signals through its inter-
action with CaMK, regulates the downstream ASK1–MKK–
JNK pathway, and thus regulates olfactory receptor expression 
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the molecular mechanism underlying Sdc2-induced dendrite 
outgrowth, we found that Sarm1 is a critical downstream   
effector of Sdc2 in dendritic arborization. Our observations also 
suggest multiple roles for Sarm1 in initiation and elongation 
of dendrites, axonal outgrowth, and neuronal polarity. This 
study thus provides new evidence that Sarm1, a molecule in-
volved in innate immunity, contributes to the regulation of neu-
ronal morphogenesis.
Results
Sdc2 regulates dendritic  
arbor morphogenesis
We noticed that dendritic arbor development seemed to be   
affected by Sdc2 while we were investigating the function 
of Sdc2 in neuronal morphology. To examine the function of   
endogenous Sdc2 in dendrite morphogenesis, we knocked 
down endogenous Sdc2 with a Sdc2-specific small hairpin 
RNA (shRNA) construct (Lin et al., 2007) for 4 d starting at 
13 DIV. Although the primary dendrite number was not changed 
by knockdown of Sdc2, the total dendrite length was reduced   
(Fig. 1 A). Previous studies had demonstrated that overexpres-
sion of Sdc2 at 1–2 DIV, when endogenous Sdc2 was unde-
tectable, accelerated the formation of dendritic filopodia and   
spines (Lin et al., 2007). To study the gain-of-function pheno-
type of Sdc2 on dendrite outgrowth, Sdc2 was again over-
expressed in cultured hippocampal neurons at 1–2 DIV. Compared 
with vector control, Sdc2 overexpression increased the total 
length of dendrites as well as the number of primary dendrites 
(Fig. 1 B). Collectively, these observations suggest that Sdc2 not 
only regulates spine formation but also plays a role in dendritic   
arbor morphogenesis.
(Chuang and Bargmann, 2005). In mammals, Sarm1 also regu-
lates neuronal survival by targeting JNK3 to the mitochondria 
(Kim et al., 2007). Although TLR3 has been shown to regulate 
neurogenesis and neuritogenesis, it remains unclear whether 
Sarm1 plays a role in neural development.
Syndecan-2 (Sdc2), a member of the transmembrane hepa-
ran sulfate proteoglycan syndecan family, is highly concentrated 
at synapses (Hsueh et al., 1998). During neuronal differentiation, 
Sdc2 is expressed concurrently with synaptogenesis (Ethell and   
Yamaguchi, 1999; Hsueh and Sheng, 1999). In cultured hippo-
campal neurons, very low expression of Sdc2 begins 1 wk after 
plating and continuously increases during neuronal maturation.   
Overexpression of Sdc2 in cultured hippocampal neurons at 
1–2 d in vitro (DIV) promotes dendritic filopodia formation 
at 4–5 DIV. These dendritic filopodia then transform into den-
dritic spines at 8–9 DIV (Ethell and Yamaguchi, 1999; Lin 
et al., 2007), 1 wk earlier than in the intrinsic process. To 
promote filopodia formation, an interaction between Sdc2 and 
neurofibromin is required; neurofibromin then activates protein 
kinase A (PKA) and triggers phosphorylation of the Ena/VASP   
proteins, thus promoting bundle formation of actin and filo-
podia formation (Lin et al., 2007). The extreme C-terminal tail of 
Sdc2, which contains a calcium/calmodulin-dependent serine 
protein kinase (CASK)-binding motif, is required for the trans-
formation from dendritic filopodia to spine (Lin et al., 2007). 
CASK, a membrane-associated guanylate kinase, contains several 
protein–protein interacting domains and functions as an adaptor 
(Hsueh, 2006, 2009). CASK links Sdc2 to the actin cytoskel-
eton through its PDZ domain and protein 4.1-binding motif, 
thereby stabilizing spine morphology (Chao et al., 2008).
In this paper, we show that, in addition to spinogenesis, 
Sdc2 also regulates dendritic arborization. By investigating 
Figure 1.  Sdc2 regulates dendritic arborization. (A) Knockdown of Sdc-2 in mature neurons reduces dendritic arborization. At 13 DIV, cultured hippo-
campal neurons were transfected with either an Sdc2 shRNA (Sdc2i) or a vector control (pSuper.neo+GFP, abbreviated as pSuper). Dendritic arbors 
were analyzed at 17 DIV. Because pSuper co-expresses the GFP–neo fusion and the shRNA, GFP signals were used to outline cell morphology. (B) Sdc2 
expression induces dendrite outgrowth in young neurons. Sdc2 and GFP were cotransfected into hippocampal neurons at 2 DIV, and cell morphology was 
analyzed at 5 DIV. Only GFP signal is shown here. The number of primary dendrites and the total dendritic length of transfected neurons were measured 
in three independent experiments. Equal numbers of transfected neurons were analyzed. Mean values ± SEM are shown (error bars). **, P < 0.005;   
***, P < 0.0005. Bars, 30 µm.771 Sarm1 regulates neuronal morphology • Chen et al.
mouse brain extracts that was not present in the precipitate of 
GST alone or GST–Sdc2 fusion protein without incubation 
with brain extracts (Fig. S1 B). Analysis by mass spectrometry 
identified this protein species as Sarm1 (Fig. S1 C).
To validate the interaction between Sdc2 and Sarm1, spe-
cific rabbit polyclonal and mouse monoclonal antibodies against 
Sarm1 were generated (Fig. S1, D and E). An immunoblot of 
the GST pull-down products from P21 mouse brain extracts in-
dicated that Sarm1 does associate with GST–Sdc2 (Fig. 2 A).   
This interaction is specific because GST alone did not precipitate 
Sarm1 interacts with Sdc2
Although the Ena/VASP proteins act downstream of Sdc2 in 
dendritic filopodia formation (Lin et al., 2007), inhibition of 
Ena/VASP activity did not impair Sdc2-induced dendritic out-
growth (unpublished data). Therefore, we set out to identify the 
factors that function downstream of Sdc2 in dendritic arboriza-
tion by searching for novel Sdc2-interacting proteins. In addition 
to known Sdc2-interacting proteins such as neurofibromin and 
CASK (Fig. S1 A), our GST–Sdc2 fusion protein also precipi-
tated an 80-kD protein species from postnatal day 21 (P21)   
Figure 2.  Sarm1 interacts with the cytoplasmic domain of Sdc2. (A) GST–Sdc2 pull-down assay with extract prepared from P21 mouse brain and immuno-
blotted (IB) with Sarm1 antibody. GST alone was used as a control. (B) Co-immunoprecipitation of Sdc2 and Sarm1 from mouse brain. Sdc2 antibodies 
and nonimmune rabbit IgG were used in the immunoprecipitation. The precipitates were immunoblotted with Sarm1 and Sdc2 antibodies as indicated. The 
arrowhead indicates the position of Sarm1. Because of the heterogeneity of glycosylation, SDS-PAGE resulted in a ladder of Sdc2-immunoreactive bands. 
(C) Schematic of Sdc2 constructs. TM, transmembrane domain; C1, conserved region 1; V, variable region; C2, conserved region 2; Myr, myristoylation 
modification. (D) Sdc2 directly interacts with Sarm1. Sdc2-GST fusion proteins were used to pull down purified MBP-Sarm1 fusion protein in the presence 
of glutathione agarose. The presence of Sarm1 in the precipitate was examined by immunoblotting with MBP antibody. The relative amounts of GST   
fusions used in the pull-down assay are indicated by Coomassie blue staining. Sdc2 forms an SDS-resistant dimer through its transmembrane domain. The 
Sdc2 dimer and monomer are marked by the arrowhead and arrows, respectively. (E) The cytoplasmic domain of Sdc2 is sufficient for the interaction with 
Sarm1. HEK293T cells were cotransfected with HA-G-S2C, Myc-tagged Sarm1, and vector control, as indicated. Immunoprecipitation was performed using 
a Myc-tag antibody. The precipitates were then analyzed by immunoblotting with Myc and HA antibodies. The positions of HA-G-S2C and immunoglobulin 
light chain (IgL) are indicated. (F) Three regions (C1, V, and C2) are involved in the interaction with Sarm1. Various GST–Sdc2 fusion proteins were used 
to pull down Sarm1 from mouse extract. The results were immunoblotted with Sarm1 antibody. Coomassie blue stain indicated the relative amounts of GST 
fusions used in the pull-down assay. Molecular mass standards (kD) are indicated next to the gel blots.JCB • VOLUME 193 • NUMBER 4 • 2011   772
Figure 3.  Sarm1 is widely expressed in rodent brain and neurons. (A) Immunoblot of Sarm1 in different mouse organs. GAPDH is used as an internal 
control. (B) Regional distribution of Sarm1 in mouse brain. Cx, cerebral cortex; Hi, hippocampus; St, striatum; Th, thalamus; Cb, cerebellum; BS, brain 
stem. -Tubulin was used as an internal control. (C) Staining patterns of Sarm1 in mouse brain. The top right shows the merged image of the MAP2/Sarm1 
double stain in the CA1 region of the hippocampus. The top left and bottom panels depict the Sarm1 patterns in brain regions including layer five of the 
somatosensory cortex (Cx), the posterior thalamic nuclear group (Th), and the caudate putamen of the striatum (St). 2-mo-old mice were used in A–C.   
(D) Developmental expression profile of Sarm1. The plotted relative Sarm1 protein expression levels were obtained by normalization to the correspond-
ing -tubulin protein amounts. The results are the means of three independent experiments. Error bars indicate SEM. (E) Distribution of Sarm1 protein in 
biochemical subcellular fractions of adult mouse brain. H, total homogenate; P1, nuclei and cell debris; S1, supernatant of P1; P2, crude synaptosomal 773 Sarm1 regulates neuronal morphology • Chen et al.
Sarm1 from the mouse brain (Fig. 2 A). The in vivo interaction 
between Sarm1 and Sdc2 was confirmed by coimmunoprecipi-
tation of Sarm1 and Sdc2 from P21 mouse brain using Sdc2 
antibody (Fig. 2 B). Control IgG precipitated neither Sarm1 nor 
Sdc2 (Fig. 2 B). Sdc2 appeared as a ladder of protein species 
on the SDS-PAGE gel because of the heterogeneity of hepa-
ran sulfate modification (Fig. 2 B, bottom). Some of the Sdc2 
immunoreactivities in the input lane were not enriched in the 
precipitate of Sdc2 antibody. This result may be caused by a 
cross-reactivity of the Sdc2 antibody in immunoblotting. Alter-
natively, the accessibility of Sdc2 antibody to variant native 
Sdc2 proteins in brain extracts could differ because of the differ-
ent heparan sulfate conjugation sites and various glycosylation 
levels. Some of the variants might therefore not be enriched by 
the Sdc2 antibody.
The direct interaction between Sdc2 and Sarm1 was fur-
ther interrogated with an in vitro binding assay using purified 
maltose-binding protein (MBP)-Sarm1 and various Sdc2 fusion 
proteins (Fig. 2 C). Glutathione agarose precipitated MBP-
Sarm1 in the presence of wild-type GST–Sdc2 (Fig. 2 D). GST 
fusions containing the ectodomain of Sdc2 alone (EC) or con-
taining an Sdc2 mutant lacking the cytoplasmic tail (dC) lost the 
ability to precipitate MBP-Sarm1 from the solution (Fig. 2 D),   
which indicates a direct interaction between Sarm1 and the 
cytoplasmic domain of Sdc2. To confirm this interaction, Myc-
tagged Sarm1 was cotransfected into HEK293T cells with a 
GFP fusion protein containing the cytoplasmic domain of Sdc2 
(HA-G-S2C).  Coimmunoprecipitation  revealed  that  the  Myc 
tag antibody precipitated Sarm1 proteins as well as HA-G-S2C 
from cell extracts (Fig. 2 E). In the absence of Myc-tagged 
Sarm1, the Myc tag antibody did not precipitate HA-G-S2C 
(Fig. 2 E), which suggests the specificity of immunoprecipita-
tion. Collectively, these data support the conclusion that the cyto-
plasmic domain of Sdc2 interacts with Sarm1.
To further define the region of Sdc2 that interacts with 
Sarm1, mutants specifically lacking the C1, V, or C2 regions were 
generated (Fig. 2 C). Among these mutants, the mutant missing 
the V region (dV) exhibited the weakest interaction with MBP-
Sarm1 (Fig. 2 F). Although Sarm1 still interacted with the dC1 
and dC2 mutants, these interactions were weaker than that of 
wild-type GST–Sdc2 (Fig. 2 F). These observations suggest that 
all three regions of Sdc2 contribute to Sarm1 binding, although 
the V region appears to be most critical for this interaction.
Distribution of Sarm1 in mouse brain  
and neurons
Previous studies have indicated that Sarm1 mRNA is mainly 
expressed in brain (Kim et al., 2007; Szretter et al., 2009), an 
observation we confirmed with Sarm1 protein in the brains of 
2-mo-old mice (Fig. 3 A). Sarm1 protein was widely distributed 
in various brain regions, as revealed by immunoblotting (Fig. 3 B) 
and indirect immunofluorescence staining (Fig. 3 C). During 
development, Sarm1 protein was expressed at a higher level from 
embryonic day 18 (E18) to P14 in the mouse brain (Fig. 3 D).
At the subcellular level, Sarm1 proteins were widely dis-
tributed in different regions, including the light membrane frac-
tion, the lysed synaptosomal membrane fraction, and the crude 
synaptic cytoplasmic fractions (Fig. 3 E). Immunofluorescence 
staining also revealed a wide distribution of Sarm1 protein (Fig. 3, 
C and F) with a punctate pattern in soma and dendrites. Com-
pared with PSD-95, a postsynaptic density marker, the Sarm1 
puncta were smaller in size and widely distributed along den-
drites (Fig. 3 F, left). However, some Sarm1 puncta colocalized 
with PSD-95 (Fig. 3 F, top right, arrowheads), whereas others 
were surrounded by or adjacent to PSD-95 (Fig. 3 F, top right, 
arrows). The correlation coefficient of PSD-95 and Sarm1 co-
localization was 0.26. Although the colocalization coefficient 
was not high, shifting the image overlap by 1 or 1.66 µm sig-
nificantly reduced the colocalization coefficient to 0.18 or 0.15, 
respectively (Fig. 3 F, bottom right; original vs. 1-µm shift, P = 
0.0096; original vs. 1.66-µm shift, P = 0.0012). These analyses 
suggest that Sarm1 distributes along dendrites and that a frac-
tion of Sarm1 is present at synapses.
Sarm1 is critical for maintenance of the 
dendritic arbor
To investigate the biological function of Sarm1 in neurons, two 
Sarm1 shRNAs—Sarm1i
1 and Sarm1i
2—were used to knock 
down Sarm1 expression. The knockdown efficiency was first 
examined in COS-1 cells, where both Sarm1i
1 and Sarm1i
2  
effectively reduced exogenous Sarm1 expression (Fig. 4 A). In 
cultured hippocampal neurons, immunofluorescence staining 
also revealed an obvious reduction in endogenous Sarm1 pro-
tein levels in Sarm1 shRNA-expressing cells. After expression 
for 2 (Fig. 4 B) or 4 d (Fig. 4 C), Sarm1i
1 reduced the Sarm1 
protein levels in cultured hippocampal neurons (not depicted 
for Sarm1i
2). Compared with the pSuper vector control, Sarm1 
knockdown neurons exhibited a dramatic reduction in the den-
dritic arbor (Fig. 4 D). We detected remarkably reduced den-
drite length (Fig. 4 F) and dendrite number (Fig. 4 G) that led 
to a large reduction in the number of dendritic intersections, as 
revealed by Sholl analysis (Fig. 4 E). Expression of Sarm1i-
resistant silent mutant constructs (Fig. 4 A) rescued the effect 
of the Sarm1 shRNAs to some extent (Fig. 4, D, F, and G). Pos-
sible causes for the partial rescues by these Sarm1 mutants are 
presented in the Discussion section.
To further confirm the specificity of Sarm1i on dendritic arbo-
rization, we included two additional controls besides pSuper. One 
is a nonsilencing control (shCtrl) that expresses an shRNA sharing 
no significant sequence homology with mammalian genomes. 
fraction; S2, supernatant of P2; LP1, lysed synaptosomal membrane; LS1, supernatant of LP1; P3, light membrane fraction; S3, soluble cytosolic fraction. 
PSD-95 enriched in the P2 and LP1 fractions was used as a quality control of fraction preparation. Molecular mass standards (kD) are indicated next to 
the gel blots. (F) Distribution of PSD-95 (red) and Sarm1 (green) in cultured hippocampal neurons at 21 DIV. Representative high-magnification images are 
shown on the top right. Arrowheads indicate the Sarm1 puncta overlapping with PSD-95; arrows indicate the Sarm1 puncta adjacent to PSD-95 puncta. 
The percentage of overlapped Sarm1 and PSD-95 is shown on the bottom right. The original images and the overlays shifted for 1 and 1.66 µm were 
analyzed. Error bars indicate mean values ± SEM. **, P < 0.01; ***, P < 0.005. Bars: (C) 30 µm; (F, left) 20 µm (F, top right) 2 µm.
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Figure 4.  Sarm1 is critical for dendritic arborization in cultured hippocampal neurons. (A) Sarm1 knockdown in COS-1 cells via cotransfection of Sarm1i
1, 
Sarm1i
2, or pSuper control and Myc-tagged wild-type Sarm1 or specific silent mutants resistant to Sarm1i
1 and Sarm1i
2 (mt1 and mt2). Immunoblotting 
was performed with Myc tag and -tubulin antibodies. Molecular mass standards (kD) are indicated next to the gel blots. (B and C) Knockdown of Sarm1 
in cultured hippocampal neurons. Neurons were transfected with the indicated plasmids at 0 (B) or 5 DIV (C) and immunostained with Sarm1 and GFP 
antibodies at 2 (B) or 9 DIV (C). Arrows point to transfected neurons. (D) Sarm1 knockdown affects dendritic arbors. At 13 DIV, cultured hippocampal 
neurons were transfected using the plasmids indicated. Neuronal morphology was monitored by GFP signals at 17 DIV. (E) Sholl analysis of the effect of 
Sarm1 knockdown. ***, P < 0.001. (F) Total dendrite length. (G) The number of primary dendrites. ***, P < 0.0005. (H) The specificity of the effect of 
Sarm1 knockdown on dendrite outgrowth was confirmed by two additional controls. The experiment was performed as described in D, except that both 
shCtrl and shLuc were also included. Representative images and analysis of total dendrite length are shown. Equal numbers of transfected neurons, as 
indicated, were analyzed. Means ± SEM are shown (error bars). Experiments were performed in triplicate. Bars, 30 µm.775 Sarm1 regulates neuronal morphology • Chen et al.
The total dendritic length of neurons transfected with shCtrl was 
comparable with that of neurons transfected with vector alone 
(Fig. 4 H). The other is shLuc, which expresses an shRNA 
against the luciferase gene. Alvarez et al. (2006) found that the 
expression of shLuc activates the interferon pathway and re-
duces the number of dendritic branches and the number and size 
of dendritic spines in cultured brain slices (Alvarez et al., 2006). 
In cultured hippocampal neurons, shLuc also reduced the total 
dendrite length compared with either vector control or shCtrl 
(Fig. 4 H). However, Sarm1i
1 had a much stronger effect than 
shLuc (Fig. 4 H), which supports a specific role of Sarm1 in 
dendritic arbor formation.
Sarm1 knockdown also influenced the number and mor-
phology of dendritic spines in mature neurons. In Sarm1 knock-
down  neurons,  mushroom-shaped  or  stubby  dendritic  spines 
were still present, but with lower density along dendrites (Fig. 5,   
A and B). We noticed that the remaining dendritic spines in 
Sarm1 knockdown neurons are longer and that their spine heads 
are larger compared with those in neurons transfected with vec-
tor control (Fig. 5, A and B). These data suggest that Sarm1 also 
influences the density and morphology of dendritic spines.
Knockdown of Sarm1 reverses the ratio of 
dendrite growth rate to pruning rate
Time-lapse experiments were then performed to further investi-
gate the effect of Sarm1 on dendritic arborization. Primary den-
drites were relatively stable in control neurons (Fig. 6 A, top; 
and Video 1), and the total dendrite lengths of the control neu-
rons were maintained almost constantly (Fig. 6 C). In contrast, 
the dendritic arbors of Sarm1 knockdown neurons gradually   
became smaller during the recording period (Fig. 6 A, bottom; 
and Video 2), and Sarm1 knockdown shortened the total den-
dritic lengths (Fig. 6 C). In Sarm1 knockdown neurons, some 
dendrites were constantly pruned back (Fig. 6 B, arrowheads); 
another population of dendrites tried to extend but were even-
tually pruned back (Fig. 6 B, arrows). The residual structures 
from retracting dendrites persisted as long and thin filopodium-
like structures at the tips of the retracting dendrites (Video 3). 
Some dendrites extended back into these residual structures and 
then withdrew again. We also measured the dendrite growth and 
pruning rates of individual neurons. In control neurons, the den-
drite growth rate was consistently higher than the pruning rate 
(Fig. 6 D), but the dendrite pruning rate was consistently higher 
than the growth rate in Sarm1 knockdown neurons (Fig. 6 D). 
Therefore, the ratio of growth rate to pruning rate was lower in 
Sarm1 knockdown neurons (Fig. 6 E). Collectively, these time-
lapse analyses provide evidence for a critical role of Sarm1 in 
maintaining dendritic arbors by controlling dendritic growth 
and pruning rates.
Sarm1 also controls dendrite initiation  
and elongation
We also examined whether Sarm1 regulates initiation and elon-
gation of neuronal dendrite outgrowth. Sarm1i
1 was transfected 
into cultured hippocampal neurons at 2 or 5 DIV, and neuronal 
morphology was monitored 3–4 d later. Similar to the data ob-
tained from cultures 2 wk old (Fig. 4, D–G), knockdown of 
Sarm1 in younger neurons also resulted in shorter total den-
drite length and fewer primary dendrites (Fig. 7, A and B; and 
Fig. 8). In contrast, overexpression of Sarm1 at 5 DIV led to an 
Figure 5.  Sarm1 knockdown influences spine morphology and density in mature neurons. (A) Dendritic spine morphology. At 13 DIV, cultured hippocam-
pal neurons were transfected with Sarm1i
1 or pSuper vector control. 4 d later, cells were fixed and stained with GFP antibodies. A region indicated by the 
arrows in the whole cell image is shown enlarged in on the bottom. Bars: (top) 30 µm; (bottom) 5 µm. (B) Quantification of the spine density, the width of 
the spine head, and the length of spines. Error bars indicate mean values ± SEM. ***, P < 0.0005.JCB • VOLUME 193 • NUMBER 4 • 2011   776
examined neuronal morphology at 2 DIV. Approximately 40% 
of Sarm1 knockdown neurons failed to establish neuronal po-
larity at 2 DIV; in contrast, only 10% of control neurons were 
still unpolarized (Fig. 7 E), which suggests that Sarm1 is also 
involved in the establishment of neuronal polarity.
To further confirm that Sarm1 influences neuronal polar-
ity, we included shCtrl and shLuc in the experiment. The results 
showed that, unlike Sarm1i
1, neither shLuc nor shCtrl resulted 
in an increase in the percentage of unpolarized neurons of cul-
tured hippocampal neurons (Fig. 7 F), which supports the speci-
ficity of Sarm1i
1 on impairment of neuronal polarization.
Sarm1 acts downstream of Sdc2
The preceding experiments provided evidence that Sarm1 plays 
multiple roles in dendritic and axonal outgrowth, that Sdc2   
increase in the total dendrite length and dendrite number at   
9 DIV (Fig. 7 B). These observations suggest that Sarm1 contrib-
utes to the initiation and elongation of dendritic growth.
Sarm1 regulates axonal outgrowth and 
neuronal polarity
Significant Sarm1 signals were found along axons and at the 
growth cone in young neurons (Fig. 7 C). At 3 DIV, the lengths 
of the longest neurites, presumably the axons, of neurons trans-
fected with Sarm1i
1 at 1 DIV were measured and found to be 
shorter than the Sarm1 knockdown neurons (Fig. 7 D), which 
suggested that Sarm1 is also required for axon outgrowth.
Sarm1 knockdown also influenced the initiation of axon 
development. 4 h after plating, we transfected the Sarm1i
1 con-
struct and vector control into cultured hippocampal neurons and 
Figure 6.  Time-lapse study of the effect of Sarm1 knockdown on dendrite morphology. Cultured hippocampal neurons were transfected with Sarm1i
1 or 
pSuper at 13 DIV. The images were recorded 10 min/frame for 24 h starting from 15 DIV. (A) Representative images of a control neuron (pSuper; top) 
and a Sarm1 knockdown neuron (Sarm1i; bottom). Bar, 30 µm. (B) Enlarged local images of neurons transfected with Sarm1i
1. Arrowheads indicate a 
continuously retracting dendrite, whereas the arrows denote a dendrite that outgrew first and then retracted. Bar, 5 µm. (C) The relative dendrite length of 
individual neurons during the recording period. (D) The growth and pruning rates of individual neurons; the rates of individual neurons are connected with 
a line. (E) The means of the ratio of growth rate to pruning rate (n = 5). Error bars indicate mean values ± SEM. **, P < 0.005.777 Sarm1 regulates neuronal morphology • Chen et al.
arborization  but  not  dendritic  filopodia  formation.  Because 
Sdc2-induced filopodia are the precursors of dendritic spines 
(Lin et al., 2007), Sarm1 is likely not involved in the initiation 
of dendritic spine formation.
Sarm1 regulates microtubule stability
As microtubule dynamics has been implicated as critical for 
neurite outgrowth and differentiation (Witte et al., 2008; Poulain 
and Sobel, 2010; Stone et al., 2010), we wondered whether 
Sarm1 influences microtubule stability to control dendrite and 
axon outgrowth. In COS-1 cells, Sarm1 overexpression increased 
tubulin acetylation nearly twofold compared with vector control 
(Fig. 9 A). In mouse neuroblastoma Neuro-2A cells expressing 
endogenous Sarm1 proteins, tubulin acetylation was reduced 
when endogenous Sarm1 was knocked down (Fig. 9 B). Collec-
tively, these analyses suggest that Sarm1 participates in micro-
tubule stabilization in cells.
participates in dendritic arborization, and that Sdc2 interacts with 
Sarm1. We next addressed our original question of whether 
Sdc2 regulates dendritic arborization through Sarm1. Sarm1i
1 
was cotransfected with Sdc2 into cultured hippocampal neu-
rons at 2 DIV (Fig. 8 A). At 5 DIV, compared with transfec-
tion of Sdc2 alone, knockdown of Sarm1 obviously reduced 
the total dendrite length and the number of primary dendrites 
induced by Sdc2 overexpression (Fig. 8, B and C), which sug-
gested that Sarm1 mediates the effect of Sdc2 on dendritic ar-
borization. The dendrite lengths of Sarm1 knockdown neurons 
were also shorter than those of control neurons (Fig. 8, B and C), 
which suggests that in addition to Sdc2, Sarm1 can also re-
ceive signal from other upstream factors to regulate dendritic 
arbor formation. The filopodia induced by Sdc2 overexpres-
sion appeared to be unaffected in Sarm1 knockdown neurons 
(Fig. 8, A and D). These observations support the hypothesis 
that Sarm1 acts downstream of Sdc2 to regulate dendritic 
Figure 7.  Sarm1 regulates development of dendrites and axons. Cultured hippocampal neurons were transfected with vector control, Sarm1i
1, or Sarm1 
at 2 (A), 5 (B), 1 (D), or 0 DIV (E), and harvested for immunostaining at 6 (A), 9 (B), 3 (D), or 2 (E) DIV. (A) Sarm1 regulates dendritic initiation. (B) Sarm1 
contributes to dendrite elongation, as indicated by the total dendrite length and primary dendrite number. (C) Sarm1 is expressed in neurites. At DIV 2, 
cultured hippocampal neurons were immunostained with Sarm1 (viewed by Alexa Fluor 488) and Tuj1 (viewed by Alexa Fluor 555) antibodies. (D) Sarm1 
knockdown shortens the length of the longest neurites. (E and F) Sarm1 regulates neuronal polarity. 4 h after plating, cultured hippocampal neurons were 
transfected with Sarm1i
1 or vector control (E) or Sarm1i
1, shCtrl, shLuc, or pSuper vector control (F), and the percentage of neurons that did not develop 
a dominant neurite (axon) was determined (see Materials and methods for details). Mean values ± SEM (error bars) are shown from three independent 
experiments in which equal numbers of transfected neurons were analyzed. Bars: (A, B, D, and E) 30 µm; (C) 20 µm. *, P < 0.05; ***, P < 0.0005.JCB • VOLUME 193 • NUMBER 4 • 2011   778
transgenic  lines  were  examined.  Compared  with  the  Sarm1 
protein levels measured in wild-type littermates, Sarm1 levels 
were lower in all three transgenic lines, especially in transgenic 
lines 1 and 3 (Fig. 10 C). Accordingly, the GFP expression 
levels were higher in those two lines than in line 2 (Fig. 10 C).   
Although the gross morphological characteristics of the Sarm1 
knockdown brains were comparable to those of wild-type 
littermates  (Fig.  S2 A),  the  total  brain  weights  of  Sarm1 
knockdown mice were 5–10% lighter than those of wild-type 
littermates at the ages of P14, P28, and P60 (Fig. 10 D). Mea-
surement of brain size by summing the total area of brain sec-
tions also indicated that Sarm1 knockdown brains were 10% 
smaller than those of wild-type littermates at P14 (Fig. 10 E). In 
some mice, Sarm1 knockdown resulted in smaller hippocampal 
volumes (Fig. S2 B). To investigate whether the dendritic arbors 
were affected in Sarm1 knockdown mice, we used Golgi-Cox 
staining to analyze neuronal morphology. Dendritic arbors of 
CA1 neurons were less complex in Sarm1 knockdown mice 
(Fig. 10 F), as reflected by a decrease in the number of dendritic 
intersections in the Sholl analysis (Fig. 10 G) and in the length 
of basal and apical dendrites (Fig. 10 H). Thus, these analyses 
provide clear evidence that Sarm1 regulates dendritic arboriza-
tion in vivo.
Discussion
The observations we describe here suggest multiple roles of 
Sarm1 in neuronal morphogenesis. Sarm1 contributes to the ini-
tiation, elongation, and maintenance of dendritic arbors, and 
influences axonal outgrowth and neuronal polarization. The 
MKK4–JNK pathway mediates the functions of Sarm1 in neuronal 
morphogenesis. Our investigation also demonstrates that Sdc2, a 
synaptic heparan sulfate proteoglycan, is one of the upstream 
Sdc2 and Sarm1 regulate  
dendritic arborization through the  
MKK4–JNK pathway
In C. elegans, Sarm1 regulates the ASK1–MKK–JNK path-
way to control expression of olfactory receptors (Chuang and 
Bargmann, 2005). In addition to phosphorylating transcription 
factors, JNK can phosphorylate microtubule-associated pro-
teins and affect microtubule stability and dendrite morphology 
in mammals (Chang et al., 2003; Björkblom et al., 2005; Rosso 
et al., 2005; Tararuk et al., 2006; Podkowa et al., 2010). We 
therefore wondered whether Sarm1 regulates neuronal mor-
phology through the JNK pathway. To examine this possibil-
ity, the JNK inhibitor SP600125, a JNK kinase dead mutant 
(JNK
KR), and a microtubule-associated protein kinase kinase-4 
(MKK4) dominant-negative mutant (MKK4
DN) were included 
in our experiments. The total dendrite length induced by Sarm1 
overexpression was shortened by all of these treatments (Fig. 9,   
C and D), which indicates that Sarm1 controls dendritic arbori-
zation through the MKK4–JNK pathway. Consistent with a role 
of Sarm1 in Sdc2–induced dendritogenesis, overexpression of 
the JNK
KR mutant also abolished Sdc2–induced dendrite out-
growth (Fig. 9 E). Collectively, these observations demonstrate 
that Sdc2 and Sarm1 regulate dendrite morphogenesis via the 
JNK pathway.
Sarm1 regulates dendritic  
arborization in vivo
To confirm the function of Sarm1 in vivo, Sarm1 miRNA knock-
down transgenic mice were generated (Fig. 10 A). In brief, two 
miRNA sequences directed against Sarm1 expression were in-
serted into the 3 untranslated region of the emGFP gene, al-
lowing use of the emGFP signals as indicators of expression 
of the artificial miRNAs (Fig. 10, B and C). Three independent 
Figure  8.  Sdc2  regulates  dendrite  outgrowth  through 
Sarm1.  (A)  Cultured  hippocampal  neurons  were  trans-
fected with the indicated plasmids at 2 DIV and then fixed 
for  immunostaining  with  GFP  and  Sdc2  antibodies  at   
5 DIV. pSuper and pGW1 are the vectors for RNAi knock-
down and gene expression, respectively. Insets (enlarged 
from the boxed regions) show the filopodia induced by 
Sdc2. Bar, 30 µm. (B) Total dendrite lengths. (C) Num-
ber of primary dendrites. (D) Density of dendritic filo-
podia. Because the vector control and Sarm1i
1 alone did 
not  obviously  induce  filopodia  formation,  only  neurons 
transfected with Sdc2 alone or both Sdc2 and Sarm1i
1 
were subjected to quantitative analysis of filopodia. Thirty 
transfected neurons were collected randomly from each 
group. The experiments were repeated three times; data 
represent mean values ± SEM (error bar). *, P < 0.05; 
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to this phenomenon. A single Sarm1 gene encodes at least three 
different protein products (UniProtKB/Swiss-Prot; http://www 
.uniprot.org/uniprot/Q6PDS3). Although Sarm1i
1 and Sarm1i
2 
target all of the splicing variants, in the rescue experiments, 
only isoform 1 was cotransfected with the Sarm1i constructs. 
Other splicing variants may also contribute to the function of 
Sarm1 in dendritic outgrowth, leading to the partial rescue by 
isoform 1. Another possibility is that dendritic arborization 
may be sensitive to Sarm1 protein levels; because it is very   
effectors of Sarm1. Sdc2 may serve as a docking site for Sarm1 
at synapses, after which Sarm1 may receive local signals and 
transduce the signals to the MKK–JNK pathway, thus maintain-
ing the dendritic arbors of mature neurons.
In this study, we used two shRNA constructs to knock 
down Sarm1 expression in cultured hippocampal neurons. Both 
constructs efficiently reduced Sarm1 expression in cells. Al-
though it is not clear why the rescue effect on dendritic arboriz-
ation was only partial, splicing variants may have contributed 
Figure 9.  The JNK pathway and microtubule stability are downstream of Sarm1 and Sdc2. (A) Sarm1 overexpression increases the acetylation levels of 
tubulin. COS-1 cells were transfected with vector control or Sarm1 and were immunoblotted with acetyl-tubulin and -tubulin antibodies. The levels of tubulin 
acetylation were normalized to total -tubulin. (B) Sarm1 knockdown reduces tubulin acetylation in mouse neuroblastoma Neuro-2A cells. 2 d after transfec-
tion, the acetylation levels of tubulin were determined by immunoblotting. (C) A JNK kinase dead mutant (JNK
KR) and an MKK4 dominant-negative mutant 
(MKK4
DN) suppress the effect of Sarm1 overexpression in dendritic arborization. (D) Sarm1-expressing neurons treated with JNK inhibitor SP600125 (SP) 
have shorter dendrites compared with Sarm1-expressing cells. In C and D, transfection was performed at 9 DIV and cells were harvested for immunostain-
ing at 12 DIV. (E) Co-expression of JNK
KR abolishes Sdc2–induced dendrite outgrowth. At 2 DIV, cultured hippocampal neurons were transfected with the 
indicated constructs, then fixed for immunostaining at 5 DIV. Three independent experiments were performed. Equal numbers of transfected neurons were 
analyzed for each experiment. The data represent mean values ± SEM (error bars). *, P < 0.05; **, P < 0.005; ***, P < 0.0005. Bars, 30 µm.JCB • VOLUME 193 • NUMBER 4 • 2011   780
Figure 10.  Reduction of Sarm1 in vivo impairs dendritic arborization. (A) Strategy used to generate Sarm1 knockdown mice; details are described in 
Materials and methods. (B) GFP expression in P5 Sarm1 knockdown transgenic (Tg) mice. (C) Reduction of Sarm1 protein levels in three independent Tg 
mouse lines. Immunoblotting was used to determine the protein levels of Sarm1 and GFP in the extracts containing forebrain and subcortical regions. For 
each line, two GFP-positive Tg and two wild-type (WT) littermates were examined. GAPDH was used as an internal control. Molecular mass standards (kD)   
are indicated next to the gel blots. (D) The relative brain weights of Sarm1 knockdown mice and WT littermates. P14, P28, and P60 mice were analyzed. 
*, P < 0.05; **, P < 0.005. (E) Total brain area of P14 mice. Sums of the total areas of a series of brain sections were determined to compare the brain 781 Sarm1 regulates neuronal morphology • Chen et al.
difficult to control exogenous Sarm1 protein levels, these levels 
may still be too low to fully rescue Sarm1 function in den-
dritic arborization.
Sarm1, the JNK pathway, and  
microtubule stability
Similar to its function in C. elegans (Chuang and Bargmann, 
2005), Sarm1 also delivers signals to the MKK4–JNK pathway 
in mammalian neurons. Multiple JNK substrates have been 
identified, including the microtubule-associated proteins MAP1 
and MAP2 and the transcription factors c-Jun and ATF2. Phos-
phorylation of MAP1 and MAP2 by JNK has been suggested   
to play a role in microtubule dynamics and dendrite outgrowth 
(Teng et al., 2001; Chang et al., 2003; Björkblom et al., 2005; 
Rosso et al., 2005; Tararuk et al., 2006; Podkowa et al., 2010). 
We also found that Sarm1 influences microtubule stability, and 
that it is possible that Sarm1 regulates local microtubule stabil-
ity through the JNK pathway.
Sarm1 also affects axonal outgrowth and neuronal po-
larity. These effects may also be caused by JNK activity and 
microtubule stability. JNK and its interacting protein c-Jun   
N-terminal kinase-interacting protein-1 have been shown to 
control axon development (Dajas-Bailador et al., 2008; Barnat   
et al., 2010; Stone et al., 2010). Microtubule stabilization speci-
fies neuronal polarity (Witte et al., 2008). In the axon, microtubule 
stability (indicated by tubulin acetylation levels) is higher than 
that in dendrites. Treatment with the microtubule stabilization 
reagent Taxol induces multiple axon formation (Witte et al., 2008). 
Because Sarm1 increases microtubule stability, it may therefore   
contribute to the establishment of neuronal polarity. In summary, 
JNK signaling and consequent microtubule stability may account 
for the multiple roles of Sarm1 in neuronal morphogenesis, al-
though we cannot rule out the possibility that JNK may regulate 
gene expression through phosphorylation of transcription fac-
tors, thus having a long-term effect on neuronal morphology.
In mature neurons, Sarm1 knockdown reduces the spine 
density but enlarges the spine head and elongates the spines. 
However, in young neurons, Sarm1 does not obviously affect the 
density of Sdc2-induced filopodia, which suggests that Sarm1 is 
not involved in the initiation of spine formation. Thus far it is un-
clear how Sarm1 regulates spine density and morphology. Per-
haps the JNK pathway is involved in this process. Alternatively, 
the changes in the dendritic spines may be indirectly caused by 
dendritic withdrawal. More investigations are required to address 
this issue.
Signals upstream of Sarm1
There  are  several  clues  suggesting  that  Sarm1  also  receives   
signals from other molecules in addition to Sdc2. First, Sarm1 ex-
pression in mouse brain or cultured hippocampal neurons occurs 
earlier than Sdc2 expression (Fig. 2; Hsueh et al., 1998; Ethell 
and Yamaguchi, 1999). In young neurons (at 2 and 5 DIV in this 
study), Sarm1 still regulates dendrite outgrowth, a regulation 
that appears to be independent of Sdc2 because Sdc2 is not yet 
expressed in young neurons. Second, Sarm1 knockdown substan-
tially shortens the total dendrite length and reduces the number 
of dendrites below baseline. Finally, Sarm1 also controls axon 
development, which is apparently also independent of Sdc2.   
Of the four mammalian syndecans, Sdc2 and Sdc3 are the two   
major syndecans expressed in neurons (Hsueh and Sheng, 1999). 
However, Sdc2 is highly concentrated at synapses, whereas 
Sdc3 is present along the axon (Hsueh and Sheng, 1999). We 
therefore suspect that the axonal function of Sarm1 is likely to 
be independent of Sdc2. However, it is currently unclear whether 
Sdc3 is relevant to the axonal function of Sarm1. More investi-
gations will be necessary to identify the other signal molecules 
upstream of Sarm1.
Sdc2-interacting proteins
Although the cytoplasmic domain of Sdc2 contains only 32 
amino acid residues, at least seven intracellular proteins, includ-
ing Sarm1, are known to interact with Sdc2: syntenin, CASK, 
synbindin, synectin, neurofibromin, and ezrin (Grootjans et al., 
1997; Cohen et al., 1998; Hsueh et al., 1998; Ethell et al., 2000; 
Gao et al., 2000; Hsueh et al., 2001; Granés et al., 2003). Syn-
tenin, CASK, synbindin, and synectin recognize the C2 region 
of Sdc2, whereas neurofibromin and ezrin require the C1 re-
gion for the interaction. Here we have shown that the C1, V, and 
C2 regions of Sdc2 participate in the interaction with Sarm1, 
although the V region seems to be most critical. Because the 
cytoplasmic domain of Sdc2 is very short, it is unlikely that a 
single Sdc2 molecule binds all these molecules simultaneously. 
However, because Sdc2 forms a dimeric or perhaps multimeric 
structure through its transmembrane domain (Asundi and Carey, 
1995; Volta et al., 2010), it is very likely that the Sdc2 complex 
binds more than one interacting protein at the same time. Thus, 
it is possible that Sdc2 can couple on the extracellular matrix to 
multiple intracellular cytoskeletal pathways (through CASK or 
ezrin) and signaling pathways (including neurofibromin–PKA 
and Sarm1–JNK) simultaneously. Of course, it is also possible 
that Sdc2 interacts with these binding partners in a different 
protein complex.
Sarm1 mouse genetic models
Compared with the effect of Sarm1 knockdown in cultured   
hippocampal neurons, the effect of Sarm1 knockdown on den-
dritic arborization in transgenic mice is moderate. The brain 
weights and sizes of Sarm1 knockdown transgenic mice are only   
5–10% less than those of wild-type littermates. This weaker 
effect in the brain may be caused by in vivo compensation. In ad-
dition to the Sarm1 knockdown transgenic mice reported here, two 
Sarm1 knockout mouse models have previously been developed. 
size of Sarm1 knockdown mice and WT littermates. **, P < 0.005. (F) Cell morphology of CA1 neurons. 2-mo-old mice were used for Golgi-Cox stain-
ing. Camera lucida was then performed to examine neuronal morphology in the brain. Bar, 50 µm. (G) Sholl analysis of CA1 neurons. *, P < 0.05;   
**, P < 0.01; ***, P < 0.001. (H) Total length of basal and apical dendrites of CA1 neurons. **, P < 0.005; ***, P < 0.0005. The data represent mean 
values ± SEM (error bars).
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2005; Alvarez et al., 2006). Myc-tagged Sarm1 mutants resistant to 
Sarm1i
1 and Sarm1i
2 were generated by site-directed mutagenesis with oligo-
nucleotides carrying the following mutations: for Sarm1i
1, 5-GAACTC-
CAAACGGACCTAG-3;  for  Sarm1i
2,  5-GAACATTGTCCCGATCATT-3 
(mutated residues are underlined). The JNK
KR and MKK4
DN constructs 
were gifts from M.-Z. Lai (Institute of Molecular Biology, Academia Sinica,   
Taipei, Taiwan).
Cell culture, transfection, and drug treatment
HEK293T and COS-1 cells were grown in culture dishes in DME/10% FBS 
at 37°C and 5% CO2. For Neuro-2A, the culture medium was MEM/10% 
FBS/1 mM sodium pyruvate. Cells were transfected with the indicated 
plasmids with Lipofectamine 2000 (Invitrogen) according to the manufac-
turer’s instructions. Hippocampal neurons from E18–19 rat embryos were 
cultured and transfected via the calcium phosphate method as described 
previously (Lin et al., 2007). In addition to the indicated constructs, a GFP 
construct was cotransfected into neurons to outline cellular morphology. 
20 µM SP600125 was added 24 h after transfection, and treatment was 
performed for 48 h.
Pull-down assay, mass spectrometry, immunoprecipitation, and in vitro 
binding assay
P21 mouse brains were lysed and homogenized in lysis buffer (PBS, pH 
7.4, 1% Triton X-100, 1 mM PMSF, and 1 µg/ml each of aproptitin, leu-
peptin, and pepstatin). For the pull-down assay, 2 µg GST or GST–Sdc2 
recombinant proteins were incubated with mouse brain lysate for 3 h. 
After washing, pull-down complexes were extracted with SDS sample 
buffer, boiled, and resolved by SDS-PAGE. Gels were then stained with 
Sypro-Ruby  (Invitrogen).  Bands  of  interest  were  excised  from  the  gel, 
trypsinized,  and  analyzed  by  LC-MS/MS  (Micromass  Q-TOF  Ultima 
API Mass Spectrometer; Waters). The Mascot search website (http://
www.matrixscience.com/search_form_select.html) was used for protein 
identification.  For  immunoprecipitation,  brain  extracts  were  incubated 
with 2 µg of the indicated antibodies and protein A– and G–Sepha-
rose beads (Sigma-Aldrich) overnight at 4°C. The precipitated complexes 
were washed and immunoblotted. For the in vitro binding assay, bead-
conjugated GST–Sdc2 proteins (2 µg) were incubated with 1 µg puri-
fied MBP–Sarm1 in PBS containing 1% Triton X-100, 1 mM DTT, and   
1 mM PMSF for 1 h at 4°C. Equal amounts of GST proteins were used 
as controls. After washing, samples were analyzed by immunoblotting 
with MBP antibody.
Immunohistochemistry, immunocytochemistry, and time-lapse recording
B6 mice were anesthetized and perfused with 4% PFA in PBS. Mouse brains 
were cut into 50-µm-thick sections with a microslicer (Dosaka). After perme-
abilization, brain sections were preincubated in 3% horse serum and 3% 
BSA in PBS for 1 h and then incubated with Sarm1 mouse monoclonal and 
MAP2 rabbit polyclonal antibodies overnight at 4°C. After washing, sec-
tions were incubated with anti-mouse and rabbit secondary antibodies con-
jugated with Alexa Fluor 488 and 555, respectively. For immunocytochemistry, 
cultured neurons were fixed in 4% PFA/4% sucrose in PBS for 10 min at 
room  temperature  followed  by  permeabilization  with  cold  methanol  at 
20°C for 10 min. For staining with PSD-95 antibody, neurons were per-
meabilized with 0.2% Triton X-100 in PBS for 10 min. Fixed neurons were 
preincubated in 5% BSA in PBS, then incubated with primary antibodies for 
2 h at room temperature or overnight at 4°C. After washing, neurons were 
further incubated with Alexa Fluor 488– and/or Alexa Fluor 555–conjugated 
secondary  antibodies.  DNA  was  counterstained  with  DAPI.  Vectashield 
Mounting medium (H-1000; Vector Laboratories) was then used to mount 
the samples for imaging. Immunofluorescent images were visualized with 
either a fluorescence microscope (DM RE; Leica) equipped with a 20×/NA 
0.70 (HC Plan-Apochromat; Leica) or a 40×/NA 1.25 (HCX Apochromat; 
Leica) objective lens or a confocal microscope (LSM 510 META or LSM 
700; Carl Zeiss) equipped with a 63×/NA 1.4 oil (Plan-Apochromat; Carl 
Zeiss) objective lens. For regular fluorescence microscopy, images were ac-
quired using a cooled charge-coupled device camera (RTE/CCD-1300-Y/HS; 
Roper Scientific) with MetaMorph software (Molecular Devices). For confo-
cal microscopy, images were captured with LSM or Zen acquisition and 
analysis software (Carl Zeiss). All fixed cells or brain slices were imaged at 
20–22°C. For time-lapse recording, the GFP signals were acquired by   
using an LSM 510 META-NLO confocal microscope equipped with a   
20×/NA 0.8 objective lens (Plan-Apochromat; Carl Zeiss) and LSM soft-
ware at 37°C with a 5% CO2 supplement. For publication, the images were 
processed with Photoshop (Adobe) with minimal adjustment of brightness or 
contrast applied to the whole images.
Kim et al. (2007) deleted exons 2–7 of mouse Sarm1 and found 
that Sarm1 is required for stress-induced apoptosis of hippo-
campal neurons. Szretter et al. (2009) removed exons 1 and 2 
of mouse Sarm1 and demonstrated that Sarm1 is involved in 
restricting West Nile virus replication in the brainstem. How-
ever, because the global brain anatomy of Sarm1 knockdown 
mice is only slightly different from that of wild-type littermates, 
those studies may have missed the morphological distinction in 
Sarm1 mutant mice.
Sarm1 and TLR signaling
Sarm1 was originally identified as a negative regulator of the 
adaptor protein TRIF that acts downstream of TLR3 and TLR4 
in the innate immune response (Carty et al., 2006). Because it has 
been shown that TLR3 is a negative regulator of axon growth in 
dorsal root ganglion neurons (Cameron et al., 2007), it will be 
interesting to investigate whether Sarm1 also acts downstream 
of TLR3 in axon outgrowth. We are also intrigued by the notion 
that TLR3 may be involved in the regulation of dendrite out-
growth. Because defects in neurodevelopment may lead to neuro-
psychiatric dysfunction, another issue worth exploring is the 
involvement of Sarm1 in neurodevelopmental disorders related 
to innate immunity.
Materials and methods
Animals
All animal experiments were performed with the approval of the Academia 
Sinica Institutional Animal Care and Utilization Committee and in strict   
accordance with its guidelines and those of the Council of Agriculture Guide-
book for the Care and Use of Laboratory Animals. Animals were housed in 
the animal facility of the Institute of Molecular Biology, Academia Sinica, 
under controlled temperature and humidity.
Antibodies and chemicals
Sarm1 polyclonal and monoclonal antibodies were generated using MBP-
Sarm1 (amino acids 1–410) recombinant proteins to immunize rabbits and 
mice, respectively. The Sdc2 antibody was generated using a GST–synde-
can-2 (residues 33–211) recombinant protein as antigen and affinity puri-
fied using protein A–Sepharose (Lin et al., 2007). The following commercial 
antibodies were used: rabbit polyclonal Sarm1 (GeneTex Inc.), rabbit poly-
clonal GFP (Invitrogen), rabbit polyclonal glyceraldehyde 3-phosphate de-
hydrogenase (GAPDH; Santa Cruz Biotechnology, Inc.), rabbit polyclonal 
MAP2 (Millipore), mouse monoclonal MBP (AbD Serotec), mouse monoclo-
nal  -actin  (Sigma-Aldrich),  mouse  monoclonal  -tubulin  (Sigma-Aldrich), 
mouse  monoclonal  PSD-95  (Millipore),  mouse  monoclonal  acetyl-tubulin 
(Sigma-Aldrich), mouse monoclonal MAP2 (Sigma-Aldrich), mouse monoclo-
nal Myc (Cell Signaling Technology), HRP-conjugated secondary antibodies 
(GE Healthcare), and Alexa Fluor 488– and Alexa Fluor 555–conjugated 
secondary antibodies (Invitrogen). SP600125 was obtained from EMD.
Plasmid construction
Sdc2 shRNA, eukaryotic expression, and GST fusion constructs have been 
described and characterized previously (Hsueh et al., 2001; Lin et al., 
2007; Chao et al., 2008). In brief, a nucleotide sequence 5-GCTTCAG-
GATTATATCCTA-3 was used for construction of Sdc2 shRNA. Full-length 
rat Sdc2 was subcloned into vector pGW1-CMV for expression in mamma-
lian cells. GST–Sdc2 fusion protein contains the amino acid residues from 
33 to 211 of rat syndecan-2. The mouse Sarm1 IMAGE clone was ordered 
from Invitrogen and further subcloned into the vector pGW1-CMV with a 
Myc tag (Wang et al., 2004) for expression in mammalian cells and into 
vector pMAL-c2X (New England BioLabs) for expression in bacteria. Two 
Sarm1 shRNA constructs were cloned into the pSuper.neo+GFP (pSuper)   
vector:  Sarm1i
1,  5-GAACTCCAGACAGACCTAG-3;  and  Sarm1i
2, 
5-GAACATTGTGCCCATCATT-3. Nonsilencing control (shCtrl), 5-CCTA-
AGGTTAAGTCGCCCT-3, and luciferase shRNA (shLuc), 5-CGTACGCG-
GAATACTTCGA-3, were also cloned into pSuper vector (Sarbassov et al.,   783 Sarm1 regulates neuronal morphology • Chen et al.
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Golgi-Cox impregnation
Adult wild-type or Sarm1 knockdown transgenic mice (2 mo old) were 
anesthetized and perfused with saline. Brains were removed and immersed 
in Golgi-Cox solution (solution A + B mixture, FD Rapid GolgiStain kit;   
FD NeuroTechnologies). 5 d after incubation, brains were immersed in solu-
tion C for 2 d and subsequently sliced into 150-µm-thick sections using a 
vibratome. Sections were mounted on gelatinized slides, developed, fixed, 
and dehydrated according to the manufacturer’s instructions. Neuronal   
images were captured by the AxioCam HR system (Carl Zeiss) and the 
camera lucida drawings were performed with Photoshop (Adobe).
Neuronal morphometry
For cultured hippocampal neurons, cotransfected or coexpressed GFP was 
used to outline neuronal morphology. Three parameters were used to deter-
mine dendritic morphology: (1) the number of primary dendrites, where the 
primary dendrites are the processes directly emerging from the soma with 
a length >20 µm; (2) the total dendrite length, including primary dendrites 
and all dendritic branches; and (3) the number of intersections in the Sholl 
analysis (Sholl, 1953). For CA1 neurons revealed by Golgi-Cox staining 
and camera lucida, the lengths of the basal and apical dendrites were 
measured separately. To analyze axonal morphology, the lengths of the 
longest neurites were measured. Because knockdown of Sarm1 in young 
neurons impaired neuronal polarization, only neurites that are twofold   
longer than the rest of other neurites were included for the analysis of axon 
length. Neural polarization was defined as the establishment of neurons 
with a dominant neurite (presumably axon) that is at least twofold longer 
than the rest of individual neurites. Dendritic spine morphology was ana-
lyzed as described previously (Lin et al., 2007; Chao et al., 2008). All 
measurements were performed using the software ImageJ.
Sarm1 knockdown transgenic mice
To construct the Sarm1 miRNA knockdown transgene, the oligonucleotide 
cassettes Sarm1i-2045 (5-TAAGCTTGTCCTCGAATTTGC-3) and Sarm1i-
2397 (5-TAAGGCAGACCCATTGGCGTA-3) were inserted into the vec-
tor cDNA6.2-GW/emGFP-miR (Invitrogen). The knockdown efficiency   
of the plasmid was examined in COS-1 cells coexpressing Sarm1. The 
transgene cassette (Fig. 10 A) under the control of the human ubiquitin 
promoter contains DsREDT3 flanked by two loxP sequences followed 
by an emGFP cassette (Wang et al., 2010). The DsREDT3 was kindly   
provided by B. Glick (Department of Molecular Genetics and Cell Biology,   
the University of Chicago, Chicago, IL). Two artificial miRNAs against 
mouse Sarm1 were inserted into the 3 end of the emGFP transcript. 
The transgene cassette also contains insulator, which was a gift from 
G. Felsenfeld (National Institute of Diabetes and Digestive and Kidney Dis-
eases, National Institutes of Health, Bethesda, MD). The entire transgene 
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into the pronuclei of fertilized C57BL/6J oocytes. Before Cre-mediated 
recombination, DsREDT3 was expressed and used to identify four red 
fluorescent founders of the transgenic mice. After crossing with E2A-Cre 
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emGFP–miRNA fusion transcripts (Fig. 10 A). E2A-cre was then washed 
out by crossing transgenic mice with wild-type C57BL/6J mice. The emGFP 
signals were used as indicators of artificial miRNA expression. Genomic 
PCR and Southern blotting additionally confirmed the genotype. For brain 
size measurement, 50-µm-thick brain sections were collected and stained 
with hematoxylin and eosin. The brain area was measured in one of every 
three brain sections from brain region Bregma 0.94 to 2.54 mm using 
the software ImageJ.
Statistical analysis
Statistical analyses were performed with the unpaired Student’s t test with 
the exception of the Sholl analyses, which were performed by two-way 
analysis of variance. Data are presented as mean ± SEM, and n indicates 
the number of neurons analyzed in each experiment.
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Fig. S1 contains the analysis of mass spectrometry and basic character-
ization of Sarm1 antibodies. Fig. S2 contains neuroanatomic analyses of 
Sarm1 knockdown mice. Video 1 is the time-lapse recording of a neuron 
transfected with pSuper vector control shown in Fig. 6 A. Video 2 is the 
time-lapse recording of a neuron transfected with Sarm1i
1 that appears in 
Fig. 6 A. Videos 1 and 2 were recorded for 24 h starting at 15 DIV. Video 3   
contains 6 h of high-magnification time-lapse imaging that highlights the 
withdrawal of dendrites and dendritic spines in a Sarm1i
1-expressing neuron. 
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